Showing results (1071-1080 of 5,692) with videos related to
Sort By:
Pageof 570
The Oncologist|January 25, 2015
The European Medicines Agency approval of axitinib (Inlyta) for the treatment of advanced renal cell carcinoma after failure of prior treatment with sunitinib or a cytokine: summary of the scientific assessment of the committee for medicinal products for human useKyriaki Tzogani, Venke Skibeli, Ingunn Westgaard, et al.The Oncologist|January 25, 2015
Differentiated thyroid cancer: focus on emerging treatments for radioactive iodine-refractory patientsJoshua J Gruber, A Dimitrios ColevasThe Oncologist|September 21, 2012
Genetically engineered cancer models, but not xenografts, faithfully predict anticancer drug exposure in melanoma tumorsAustin J Combest, Patrick J Roberts, Patrick M Dillon, et al.The Oncologist|September 14, 2012
Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: association with outcome and predictive nomogramDaniel Keizman, Maya Gottfried, Maya Ish-Shalom, et al.The Oncologist|September 28, 2012
Treatment patterns and clinical outcomes in patients with metastatic colorectal cancer initially treated with FOLFOX-bevacizumab or FOLFIRI-bevacizumab: results from ARIES, a bevacizumab observational cohort studyJohanna C Bendell, Tanios S Bekaii-Saab, Allen L Cohn, et al.The Oncologist|July 4, 2012
Variability of sorafenib toxicity and exposure over time: a pharmacokinetic/pharmacodynamic analysisPascaline Boudou-Rouquette, Stanislas Ropert, Olivier Mir, et al.The Oncologist|July 4, 2012
Safety of weightlifting among women with or at risk for breast cancer-related lymphedema: musculoskeletal injuries and health care use in a weightlifting rehabilitation trialJustin C Brown, Andrea B Troxel, Kathryn H SchmitzThe Oncologist|August 21, 2012
The relationship between body composition and response to neoadjuvant chemotherapy in women with operable breast cancerEgidio Del Fabbro, Henrique Parsons, Carla L Warneke, et al.The Oncologist|June 19, 2012
Characteristics and outcomes of methicillin-resistant staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer centerSminil N Mahajan, Jharna N Shah, Ray Hachem, et al.The Oncologist|June 19, 2012
Clinical and economic burden of emergency department presentations for neutropenia following outpatient chemotherapy for cancer in Victoria, AustraliaPatricia M Livingston, Melinda Craike, Monica SlavinPageof 570